- 
							【GE CHENG News】Avanci announces 5G connected car license rate, with Huawei, Coolpad and other Chinese companies involved2025-05-07On August 16, Avanci announced the launch of the 5G connected car project, which is to simplify the licensing process for next-generation connected cars to obtain cellular technology. Cellular Vehicle-to-Everything (C-V2X) allows a full range of connectivity and communications between vehicles and s
- 
							【GE CHENG News】Hengrui Medicine's revenue in the first half of 2023 is 11.168 billion with a net profit 2.308 billion, a year-on-year increase of 9.19% and 8.91%2025-05-07On the night of August 18, Hengrui Medicine released its performance report for the first half of 2023, which shows that Hengrui Medicine achieved an operating income of 11.168 billion yuan, a year-on-year increase of 9.19%; net profit attributable to shareholders of listed companies was 2.308 billi
- 
							【GE CHENG News】Yabao Pharmaceutical plans to transfer the traditional Chinese medicine "Chaigui granules" owned by Shanxi University for 26 million yuan2025-05-07Yabao Pharmaceutical announced on August 7 that the company signed a technology transfer agreement for new traditional Chinese medicine projects with Shanxi University on August 6, transferring the clinical trial approval documents, patent rights, and related technical information. of the Class 6.1
- 
							【GE CHENG News】Main statistical data on intellectual property rights from January to July 20232025-05-071. PatentFrom January to July 2023, the number of authorized invention patents in China was515,000, the number of authorized utility model patents was1.254 million, and the number of authorized design patents was383,000.As of the end of July 2023, the number of valid invention patents in China is 4.
- 
							【GE CHENG News】The patent war between CATL whose two patents were ruled invalid and CALB reverses2025-05-07The two-year patent war between Contemporary Amperex Technology Co., Limited(CATL)and CALB has reversed.On the evening of August 3, CALB announced that the CNIPA had issued two "Examination Decision on Request for Invalidation", respectively claiming the "lithium-ion battery" and "positive electrode
 
			